University of Calgary

Publications - 2008

  1. Abdullah AR, Smith EE, Biddinger PD, Kalenderian D, Schwamm LH. Advance hospital otification by EMS in acute stroke is associated with shorter door-to-computed tomography time and increased likelihood of administration of tissue-plasminogen activator. Prehosp Emerg Care. 2008;12:426-431.
  2. Addas BMJ, Midha R. Nerve transfers for severe nerve injuries. Spinner R, Winfree C (eds) Neurosurgical Clinics North America, 20: 27-38, Dec 2008. doi:10.1016/j.nec.2008.07.018.
  3. Almekhlafi MA, Fletcher WA.  Levator palpebrae myositis. Neurology. 71:1202, 2008.
  4. Almekhlafi MA, Hu WY, Hill MD, Auer RN.  Calcification and endothelialization of thrombi in acute stroke. Ann Neurol. 200;64:344-8.
  5. Alcalay RN, Smith EE. MRI Showing White Matter Lesions and Multiple Lobar Microbleeds in a Patient with Reversible Encephalopathy. J Neuroimaging. 2008
  6. Antel J, Arnold D, Bhan V, Bar-Or A, Bakker J, Bell B, et al.  The use of disease-modifying agents in multiple sclerosis—by the Canadian Network of MS Clinics.  Can J. Neurol Sci. 2008; 35(2):127-32.
  7. Armstrong L, Graham GE, Schimke RN, Collins DL, Kirse DJ, Costello F, Ardinger HH.  The Hunter-MacDonald syndrome with expanded phenotype including risk of meningioma:  an update and review.  Am J Med Genet A.  2008 Jan 1: 146 (1): 83 – 92.
  8. Auer RN, Dunn JF, Sutherland GR. Hypoxia and related conditions. In: S Love, DN Louis and DW Ellison (eds), Greenfield’s Neuropathology Eighth Edition. Edward Arnold (Publishers) Limited, London, 1:64-119, 2008.
  9. Becker WJ.  Headache progress in Canada over the decades.  Headache 2008; 48: 678 – 679
  10. Becker WJ, Purdy RA.  Medication Overuse Headache In Canada.   Cephalalgia 2008; 28: 1218-1220
  11. Berg A, Langfitt J, Vickrey B, Wiebe S.  “Postoperative Follow-up:  Outcome Measurement”.  In:  Epilepsy.  Engel,J.,Jr.; Pedley,T.A.  Lippincott Williams & Wilkins, Philadelphia, 2008;Volume II:1929-1937
  12. Bristow MS, Poulin BW, Simon JE, Hill MD, Kosior JC, COUTTS SB, Frayne R, Mitchel JR, Demchuk AM (2008). Modeling Infarct Growth in Acute Ischemic Stroke with MR Imaging. J Magn Reson Imaging; 28:837-846.
  13. Brown R, Zlatescu M, Sijben A, Roldan G, Easaw J, Forsyth P, Parney I, Sevick R, Yan E, Demetrick D, Schiff D, Cairncross JG, Mitchell R. Detecting Genetic Signatures in Oligodendroglioma Non-Invasively Using MR. Clinical Cancer Research 14: 2357-2362, 2008.  
  14. Busche K, Morrish WF.  Sphenoid Sinus Mucocele – Rupture Causing Brainstem
  15. Inflammation and Stroke.  Can J Neurol Sci, 34: 381-385, 2008.
  16. Brussee V, Guo GF, Dong YY, Cheng C, Martinez JA, Smith D, Glazner GW, Fernyhough P, Zochodne DW. Distal degenerative sensory neuropathy in a long term type 2 diabetes rat model. Diabetes 57(6):1664-73, 2008.
  17. Burneo JG, Tellez-Zenteno J, Steven DA, Niaz N, Hader W, Pillay N, Wiebe S.  Adult-onset epilepsy associated with dyembryoplastic neuroepithelial tumors.  Seizure 2008;17(6):498-504
  18. Casha S, Yong W, Midha R. Minocycline administration for nerve repair: a double edged sword. Commentary. Exp Neurol, 213: 245-248, 2008. DOI information: 10.1016/j.expneurol.2008.06.016
  19. Cheng C, Webber CA, Wang J, Xu YQ, Martinez JA, Liu WQ, McDonald D, Guo GF, Nguyen MD, Zochodne DW. Activated RHOA and peripheral axon regeneration. Experimental Neurology 212(2):358-69, 2008
  20. Chou SH, Smith EE, Badjatia N, Nogueira RG, Sims JR, 2nd, Ogilvy CS, Rordorf GA, Ayata C. A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:2891-2893.
  21. Claassen J, Jetté N, Chum F, Green R, Schmidt M, Choi H, Frontera JA, Connolly ES, Emerson RG, Mayer SA and Hirsch LJ.  Electrographic seizures and periodic discharges after intracerebral hemorrhage.  Author reply.  Neurology.  2008 Feb 14.
  22. Costello F, Hodge W, Pan YI, Metz L, Kardon R.  Retinal Nerve Fiber Layer and Future Risk of Multiple Sclerosis.  Canadian Journal of Neurological Sciences 2008 Sept 35: 482-487.
  23. Costello F, Hodge W, YI Pan, Eggenberger, E, and Kardon R.  Retinal Nerve Fiber Layer Changes after Optic Neuritis:   A Prospective Study with Optical Coherence Tomography. Mult Scler 2008 Aug;14 (7):893-905
  24. Coutts SB, Eliasziw M, Hill MD, Scott JN, Subramaniam S, Buchan, AM, Demchuk AM for the VISION study group).  An improved Scoring System for Identifying Patients at High Early Risk of Stroke and Functional Impairment After an Acute Transcient Ischemic Attack or Minor  Stroke.  International Journal of Stroke. 2008 3(1):3-10.
  25. Coutts SB, Hill MD, Campos CR, Choi YB, Subramaniam S, Koisor JC,  Demchuk AM; for the VISION study group. Recurrent events in Transcient Ischemic Attack and Minor Stroke: What Events are Happening and to Which Patients? Stroke 2008;39(9):2461-6.
  26. Coutts SB, Hill MD, Herrera C, Choi YB, Koisor J, Subramaniam S, Demchuk AM for the VISION Study group (2008). Recurrent events in TIA and minor stroke: What events are happening and to which patients? Stroke. 39:2461-2466.
  27. Cucchiara BL, Tanne D, Demchuk AM, Levine SR, Kasner SE.  A risk score to predict intracranial hemorrhage after rt-PA for acute ischemic stroke. J Stroke Cerebrovasc Dis. 2008 Nov-Dec; IT(6):331-3.
  28. Cunningham CJB, Zaamout MF, Goodyear BG, Federico P. Simultaneous EEG-fMRI in human epilepsy. Canadian Journal of Neurological Sciences 2008,35:420-435.
  29. Delaney L, Chambers C, Roldan G, De Robles P, Cairncross G, Forsyth P, Easaw J.  A feasibility study to assess the integration of a pharmacist into neurooncology  clinic.  J Oncol Pharm Pract. 2008 Nov 26. [Epub ahead of print]
  30. Demchuk AM, Gupta R, Khatri P.  “Emerging Therapies.” In: Miller AE, Marr CM, William MA (Eds) Continuum, Lifelong Learning in Neurology, American Academy of Neurology Vol. 14, Number 6, December 2008. St. Paul, MN:Lippincott Williams & Wilkins. 2008:76-93.
  31. Demchuk AM, Khan F, Hill MD, Barber PA, Silver B, Patel S, Levine SR for the NINDS rtPA Stroke Study Group.  Importance of Leukoaraiosis on CT for Tissue Plasminogen Activator Decision Making: Evaluation of the NINDS rt-PA Stroke Study.  Cerebrovasc Dis 2008; 26(2):120-5.
  32. Demchuk AM, Khan F, Hill MD, Barber PA, Silver B, Patel S, Levine SR. Importance of Leukoaraiosis on CT for Tissue Plasminogen Activator Decision making:  Evaluation of the NINDS rt-PA Stroke Study.  Cerebrovascular Diseases 2008;26(2):120-125
  33. de Robles P, McIntyre J, Kalra S, Roldan G, Cairncross G, Forsyth P, Magliocco A, Hamilton M, Easaw J. Methylation status of the MGMT gene promoter in meningiomas. Cancer Genet Cytogenet 187: 25-27, 2008.
  34. Drabycz S, Mitchell JR, “Texture Quantification of Medical Images Using a Novel Complex Space-Frequency Transform” The International Journal of Computer Assisted Radiology and Surgery, DOI: 10.1007/s11548-008-0219-4, 2008
  35. Fallah A, Grochmal J, Lu J-Q, diFrancesco L, Khalil M, Clark A, Midha R. Nodular fasciitis presenting in the obturator nerve and gracilis muscle. Peer Reviewed Letter. Can J Neurol Sci, 35(1):111-114, March 2008.
  36. Federico P, Alqahanti S, Myers RP. Possible new clinical sign of hyperammonemia. Canadian Medical Association Journal 2008: 178:326.
  37. FitzMaurice E, Wendell L, Snider R, Schwab K, Chanderraj R, Kinnecom C, Nandigam K, Rost NS, Viswanathan A, Rosand J, Greenberg SM, Smith EE. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke. 2008;39:2151-2154.
  38. Fletcher WA. Eye signs in patients with parkinsonism: do they predict the development of multiple system atrophy?  Nature Clin Pract Neurol. 4:540-1, 2008
  39. Forsyth PA, Roldan G, George D, Wallace C, Palmer C, Morris DG, Cairncross G, Vallee Matthews M, Markert J, Gillespie GY, Coffey M, Thompson B, Hamilton M.  A phase I trial    of intratumoral (i.t.) administration of reovirus in patients with histologically confirmed  recurrent malignant gliomas (MGs).   Molecular Therapy.  16: 627-632, 2008.
  40. Frohman EM, Costello F, Stuve O, Calabresi P, Miller DH, Hickman SJ, Sergott R, Conger A, Salter A, Krumwiede KH, Frohman TC, Balcer L, Zivadinov R.  Modeling axonal degeneration within the anterior visual system:  implications for demonstrating neuro-protection in multiple sclerosis.  Arch Neurol. 2008 Jan; 65(1): 26 – 35
  41. Giannini C, Burger PC, Berkey BA, Cairncross JG, Jenkins RB, Mehta M, Curran WJ, Aldape K.Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Radiation Therapy Oncology Group trial 9402. Am J Surg Pathol 18: 360-369, 2008.
  42. Giovannoni G, Barbarash O, Casset-Semanaz F, King J, Metz L, Pardo G, Simsarian J, Soelberg Sørensen P, Stubinski B; on behalf of the Rebif® New Formulation Study Group. Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif® New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results. Multiple Sclerosis Mult Scler. 2008 Aug 28. [Epub ahead of print]
  43. Goodman AD, Brown TR, Cohen JA, Krupp L, Shapiro R, Schwid SR, Cohen R, Marinucci LN, Blight AR for the Acorda-F202 Study Investigators. Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology. 2008 Oct 7;71(15):1134-41. Epub 2008 Jul 30
  44. Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Cairncross G, EisenhauerE, Belanger K, Brandes AA, Allgeier A, Lacombe D, Stupp R. Nomograms for predicting survival of patients with  newly diagnosed glioblastoma multiforme: a prognostic factor analysis of EORTC/NCIC trial  26981-22981/CE.3. Lancet Oncol 9: 29-38, 2008.
  45. Green TL, Mansoor A, Newcommon N, Stephenson C, Steward E, Madden B, Hill MD.  Reliability of Point-of-Care Testing of INR in Acute Stroke: a comparison with hospital laboratory testing.  Can J Neurol Sci 2008; Jul;35(3):348-51
  46. Greer AD, Newhook P, Sutherland GR. Human-machine interface for Robotic Surgery and  Stereotaxy. IEEE/ ASME Transactions on MRI Compatible Mechatronic Systems 13: 355-361, 2008
  47. Greenberg SM, Grabowski TJ, Gurol ME, Skehan ME, Nandigam RNK, Becker JA, Garcia-Alloza M, Prada C, Frosch MP, Rosand J, Viswanathan A, Smith EE, Johnson KA. Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol. 2008;64:587-591.
  48. Hader WJ, Walker RL, Myles TM, Hamilton MG. Complications of endoscopic third ventriculostomy in previously shunted patients. Neurosurgery 63 [ONS Suppl 1]: ONS170–ONS177, 2008
  49. Hauck LJ, White C, Feasby TE, Zochodne DW, Svenson LW, Hill MD Incidence of Guillain-Barré syndrome in Alberta, Canada: an administrative data study. J Neurol Neurosurg Psychiatry. 2008 Mar; 79(3):318-20
  50. Hegi M, Murat A, Migliavacca E, Gorlia T, Lambiv W, Shay T, Hamou M-F, Diserens A-C, Luca  R, Wick W, Kouwenhoven M, Hainfellner J, Heppner F, Dietrich P-Y, Zimmer Y, Macdonald D, Guha A, Merlo A, Cairncross G, de Tribolet N, Janzer R-C, Domany E, Delorenzi M, Stupp R. Self-renewal signature" and high EGFR expression associated with resistance to chemo-radiotherapy inglioblastoma. J Clin Oncol 26: 3015-3024, 2008.
  51. Holland CM, Smith EE, Csapo I, Gurol ME, Brylka DA, Killiany RJ, Blacker D, Albert MS, Guttmann CR, Greenberg SM. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke. 2008; 39:1127-1133
  52. Hurlbert J, Hamilton MG. Methylperednisolone for acute spinal cord injury: 5-year practice reversal. Canadian Journal of Neurological Sciences 35: 41-45, 2008.
  53. Iloreta A, Sarna J, Sharma P, Klein G. Radiologic findings in a patient with spinal cord dysfunction.Can J Neurol Sci (Suppl 1) May 2008 p S89
  54. Jetté N, Marson AG, Hemming K, Hutton JL. Topiramate add-on for drug-resistant partial epilepsy.  Cochrane Database Syst Rev.  Cochrane Database Syst Rev. 2008 Jul 16;3:CD001417.
  55. Jette N, Patten S, Williams J, Becker W, Wiebe  S.  Comorbidity of migraine and psychiatric disorders- a national population-based study.  Headache 2008; 48: 501 – 516.
  56. Jetté N, Quan H, Faris P, Dean S, Li B, Fong A and Wiebe S.  Health resource use in epilepsy:  disparity between aboriginals and non-aboriginals.  Epilepsia.  2008 Apr;49(4):586-93.  Epub 2007 Dec 28.
  57. Jetté N, Williams J, Patten S, Becker W and Wiebe S.  Psychiatric comorbidities in migraine patients – a population based study.  Headache.  2008 April;48(4):501-516.  Epub 2007 Dec 7.
  58. Jovin TG, Demchuk AM, Gupta R. “Pathophysiology of Acute Ischemic Stroke.” In: Miller AE, Marr CM, William MA (Eds) Continuum, Lifelong Learning in Neurology, American Academy of Neurology Vol. 14, Number 6, December 2008. St. Paul, MN:Lippincott Williams & Wilkins. 2008:29-44.
  59. Kawchuk G, Gian SJ, Hurwitz EL, Wynd S, Haldeman S, Hill MD.  Spatial distribution of vertebral artery dissections in cases associated with and without cervical manipulation.  J Neurol 2008; 255(3): 371-377
  60. Kemp SWP, Walsh S, Midha R.  Growth factor and stem cell enhanced conduits in peripheral nerve regeneration and repair. Neurol Res, 30(10): 1030-1038, December 2008.
  61. Khatri P, Hill MD, Palesch Y, Spilker J, Jauch E, Carrozzella J, Demchuk A, Martin R, Mauldin P, Dillon C, Ryckborst K, Janis S, Tomsick T, and Broderick J for the IMS III Investigators.  Methodology of the Interventional Management of Stroke (IMS) III Trial.  Int J Stroke 2008; 3(2): 130-137
  62. Khatri P, Hill MD, Carrozzella JA, Demchuk AM, Martin R, Mauldin P, Dillon C, Ryckborst KJ, Janis S, Tomsick TA, Broderick JP, for the IMS III Investigators.  Methodology of the Interventional Management of Stroke Study III.  Int J. Stroke 2008: 3:130-137.
  63. Khosravani H, Mehrotra N, Rigby M, Hader WJ, Pinnegar CR, Pillay N, Weibe S, Federico P, Spatial localization and tie-dependant changed of electrographic high frequency oscillations in human temporal lobe epilepsy.  Epilepsia.  2008 Aug 19 [Epub ahead of print}
  64. Kim DH, Midha R, Murovic JA and Spinner RJ. Kline and Hudson: Nerve Injuries. 2nd Ed, Saunders (Elsevier), Philadelphia, PA, 2008.
  65. Kiss ZHT, Anderson TR: Cellular mechanisms of action of therapeutic brain stimulation, Chapter 2 in Bronzino JD and DiLorenzo DJ (Eds): Neuroengineering, CRC Press / Taylor and Francis Group, Boca Raton, chapt 2, pp 2.1-2.20, 2008.
  66. Langfitt J T, Wiebe S.  Early surgical treatment for epilepsy.  Curr Opin Neurol 2008; 21(2):179-183.
  67. Mason W, Cairncross JG. The expanding impact of molecular biology on the diagnosis andtreatment of glioma. Neurology 71: 365-373, 2008.
  68. Mauldin P, Simpson K, Palesch Y, Spilker J, Hill MD, Khatri P, Broderick J, for the IMS III Investigators Design of the Economic Evaluation for the Interventional Management of Stroke Trial.  Int J Stroke 2008; 3(2): 138-144
  69. Mayer GS, Vrscay ER, Lauzon ML, Goodyear BG, Mitchell JR, “Self-Similarity of Images in the Fourier Domain, with Applications”, Springer-Verlag Lecture Notes in Computer Science: Image Analysis and Recognition, Campilho A, Kamel M (Eds), 5112:43-52, 2008
  70. Midha R and Zager E, Editors: Surgery of Peripheral Nerves: A Case-Based Approach. New York, Thieme, 2008.
  71. Mohile NM, Forsyth P, Stewart D, Raizer JJ, Paleologos N, Kewalramani T, Louis DN, Cairncross JG, Abrey LE. A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: An interim analysis. J Neuro-Oncol 89: 187-194, 2008. J. Neurooncol. (epub May 6, 2008
  72. Murphy BD, Fox AJ, Lee D, Sahlas D, Black S, Hogan M, COUTTS SB, Demchuk AM, Goyal M, Symons S, Gulka I, Beletsky V, Pelz D, Lee TY (2008). White Matter Thresholds for Ischemic Penumbra and Infarct Core in Patients with Acute Stroke: CT Perfusion Study.: A CT Perfusion study. Radiology; 247:818-825.
  73. Murphy BD, Fox AJ, Lee DH, Sahlas DJ, Black SE, Hogan MJ, Coutts SB, Demchuk AM, Goyal M, Aviv RI, Symons S, Gulka IB, Beletsky V, Pelz D, Chan RK, Lee TY.  White matter thresholds for ischemic penumbra and infarct core in patients with acute stroke: CT perfusion study. Radiology. 2008;247(3):818-825.
  74. Murphy W.  VNS Therapy. CJNS July 2008 Vol 35 No 3, pp 278-279.
  75. O'Connor P, Devonshire V; Canadian Network of MS Clinic (Patry DG). The use of disease-modifying agents in multiple sclerosis-by the Canadian Network of MS Clinics.
  76. Can J Neurol Sci. 2008 May;35(2):127-32. English, French   
  77. Patten SB, Williams JVA, Lavorato DH, Modgill G, Jetté N and Eliasziw M.  Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. J Hosp Psych.  2008 Sept-Oct;30(5):407-13
  78. Patten SB, Williams JV, Metz L. Antidepressant Use in Association with Interferon and Glatiramer Acetate Treatment in Multiple Sclerosis. Mult Scler. 2008 Apr;14(3):406-11. Jan 31 [Epub ahead of print
  79. Polman C, Kappos L, Freedman MS, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Selmaj K, Uitdehaag BM, Dahms S, Bauer L, Pohl C, Sandbrink R; for the BENEFIT investigators**. Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b. J Neurol. J Neurol. 2008 Apr; 255(4):480-7.
  80. Polman CH, Reingold SC, Barkhof F, Calabresi PA, Clanet M, Cohen JA, Cutter GR, Freedman MS, Kappos L, Lublin FD, McFarland HF, Metz LM, Miller AE, Montalban X, O’Connor PW, Panitch H, Richert JR, Petkau J, Schwid SR, Sormani MP, Thompson AJ, Weinshenker BG, Wolinsky JS. Ethics of Placebo-Controlled Clinical Trials in Multiple Sclerosis:  A Reassessment. Neurology 2008 Mar 25; 70(13 Pt2): 1134-40.
  81. Potucek RK, Kemp SWP, Syed NI and Midha R.  Peripheral nerve injury, repair and regeneration.  In: Strategies in Regenerative Medicine: Integrating Biology with Materials Design, ed. Matteo Santin, Springer, 2008,  ISBN 978-0-387-74659-3.
  82. Pringsheim T, Davenport WJ, Dodick D.  Evidence Based Review: Acute Treatment and Prevention of Mentrually Related Migraine Headache. Neurology 2008:70:1555-1563.
  83. Pringsheim T, Lang A, Kurlan R, Pearce M, Sandopr P.  Understanding Disability in Tourette Syndrome. Development Medicine and Child Neurology, 2008 Oct 24, Epub ahead of print.
  84. Pringsheim T, Marras C, Pimozide for tics in Tourette Syndrome (Protocol). Cochrane Database of Systemaatic Reviews 2008: Isue I, Art. No: CD006996. DOI: 10.1002/14651858. CD006996.
  85. PRoFESS Study Group.  Telmisartan to prevent recurrent stroke and cardiovascular events.  N Engl J. Med. 2008 Sep 18;359(12):1225-37.
  86. PRoFESS Study Group.  Effects of aspirin plus extended-release dipyridamole versus clopidogrel and temisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study.  Lancet Neurol. 2008 Oct; 7(10):875-84.
  87. Puetz V, Dzialoski I, Hill MD, Subramanium S, Sylaja PN, Krol A, Hudon M, , Hu WY, Coutts SB, Barber PA, Watson T, Roy J, Demchuk AM for the Calgary CTA study group (2008). Intracranial thrombus extent predicts the clinical outcome, final infarct size and hemorrhagic transformation in ischemic stroke: the clot burden score.  International Journal of Stroke. 3:230-236
  88. Puetz V, Gahn G, Becker U, Mucha D, Mueller A, Weir NU, Wiedemann B, von Kummer R. AJNR 2008;29:273-280 Endovascular therapy of symptomatic intracranial stenosis in patients with impaired regional cerebral blood flow or failure of medical therapy.
  89. Puetz V, Sylaja PN, Coutts SB, Hill MD, Dzialowski I, Mueller P, Becker U, Urban G, O’Reilly C, Barber PA, Sharma P, Goyal M, Gahn G, von Kummer R, Demchuk AM (2008). Extent of hypoattenuation on CT angiography source images predicts functional outcome in patients with basilar artery occlusion. Stroke;39:2485-2490.
  90. Reid A, Jetté N, Quan H, Hill M and Wiebe S.  Using administrative databases for research in epilepsy:  Validation of ICD-9 and ICD-10 epilepsy codes.  Neuroconnections Symposium.  Banff, AB, January 2008 (chapter in meeting book).
  91. Roldán G, Brasher P, Vecil , Senger D, Rewcastle B, Cairncross G, Forsyth P*, Hamilton M.  Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.  Can J  Neurol Sci 35:210-5, 2008.  
  92. Roldan G, de Robles P, Cairncross JG. Searching for a new treatment for anaplastic oligodendroglioma. In: New Treatment for Brain Cancer (International Oncology Updates Series). Ed. C Balaňá Quintero. Permanyer, Barcelona, Spain, 2008, pp 11-27.
  93. Roldan G, Li H, Brasher P, Vecil G, Senger D, Rewcastle B, Cairncross G, Forsyth P, Hamilton M. A population-based study of Medulloblastoma: Outcomes in Alberta from 1975-1996. Canadian Journal of Neurological Sciences 35: 210-215. 2008
  94. Roldán G, Scott JN, George D, Easaw J, Yan E, Parney I, Cairncross G, Forsyth P. Leptomeningeal disease from oligodendroglioma: a clinical and molecular analysis. Can J Neurol Sci 35: 204-209, 2008.
  95. Rosenthal ES, Schwamm LH, Roccatagliata L, COUTTS SB, Demchuk AM, Schaefer PW, Gonzalez RG, Hill MD, Halpern EF, Lev MH (2008). Role of Recanalization in Acute Stroke Outcome: Rationale for a CT Angiogram-Based "Benefit of Recanalization" Model. AJNR. Am J Neuroradiol ;29:1471-1475.
  96. Rost NS, Smith EE, Chang Y, Snider RW, Chanderraj R, Schwab K, FitzMaurice E, Wendell L, Goldstein JN, Greenberg SM, Rosand J. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke. 2008;39:2304-2309.
  97. Rubin ZA, Wiebe S.  “Social Issues:  Issues in Health Outcomes Assessment.  In:  Epilepsy.  Engel,J.,Jr., Pedley,T.A.  Lippincott Williams & Wilkins, Philadelphia, 2008;Volume III:2267-2275
  98. Sauro KM, Becker WJ.  Multidisciplinary treatment of headache in the Canadian healthcare setting.   Can J Neurol Sci 2008;35: 46 – 56
  99. Saposnik G, Fang J, O’Donnell M, Hachinski V, Kapral MK, Hill MD on behalf of the Investigators of the Registry of the Canadian Stroke Network (RCSN) for the Stroke Outcome Research Canada (SORCan) working group.  Escalating levels of Access to in-hospital care and Stroke Mortality.  Stroke 2008; Sep;39(9):2522-30.
  100. Saposnik G, Hill MD, O’Donnell M, Fang J, Hachinski V, Kapral MK, on behalf of the investigators of the Registry of the Canadian Stroke Network for the Stroke Outcome Research Canada (SORCan) Working Group.  Comparing variables associated with 7-day, 30-day and 1-year fatality after ischemic stroke .  Stroke 2008, Aug;39(8):2318-24
  101. Saqqur M, Tsivgoulis G, Molina CA, Demchuk AM, Garami Z, Barreto A, Spengos K, Forteza A, Mikulik R, Sharma VK, Brunser A, Martinez P, Montaner J, Kohrmann M, Schellinger PD, Alexandrov AV; CLOTBUST-PRO Investigators.  Design of a PROspective multi-national CLOTBUST collaboration on reperfusion therapies for stroke (CLOTBUST-PRO).  Int J Stroke.  2008 Feb;3(1):66-72.
  102. Sarna JR, Iloreta A, Sharma P, Klein G. Neuroimaging features of  cerebellar venous infarct: a case report and review of literature. Can J Neurol Sci (Suppl 1) May 2008 p S105
  103. Schmahmann JD, Smith EE, Eichler FS, Filley CM. Cerebral white matter: neuroanatomy, clinical neurology, and neurobehavioral correlates. Ann N Y Acad Sci. 2008;1142:266-309.
  104. Sherman E, Griffiths SY, Akdag S, Connolly MB, Slick DJ, Wiebe S.  Sociodemographic correlates of health-related quality of life in pediatric epilepsy.  Epilepsy & Behaviour 2008;12(1):96-101.
  105. Sijben AE, McIntyre JB, Roldán GB, Easaw JC, Yan E, Forsyth PA, Parney IF, Magliocco AM, Bernsen H, Cairncross JG. Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neuro-Oncol 89: 97-103, 2008.
  106. Smith EE, Vijayappa M, Lima F, Delgado P, Wendell L, Rosand J, Greenberg SM. Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology. 2008;7:1424-1430.
  107. Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, Tanzi RE, Albert MS, Greenberg SM, Guttmann CR. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol. 2008; 5: 4-100.
  108. Smith EE, Dreyer P, Prvu-Bettger J, Abdullah AR, Palmeri G, Goyette L, McElligott C, Schwamm LH. Stroke center designation can be achieved by small hospitals: the Massachusetts experience. Crit Pathw Cardiol. 2008;7:173-177.
  109. Speechley KN, Sang X, Levin S, Zou GY, Eliasziw M, Smith ML, Camfield C, Wiebe S. Assessing severity of epilepsy in children: preliminary evidence of validity and reliability of a single-item scale. Epilepsy Behav 2008;13:337-342.
  110. Sutherland CS, Hill MD, Kaufmann AM, Silvaggio J, Demchuck AM, Sutherland GR. Recombinant Factor VIIa plus Surgery for Intracerebral Hemorrhage. Can J Neurol Sci 35:567-572, 2008.
  111. Sutherland GR, Kelly JJP, Boehm DW, Klassen JB. Ceramic aneurysm clips for improved MR visualization. Neurosurg 62 [ONS Suppl 2]: 400-406, 2008.
  112. Sutherland GR, Newhook P, Feil G, Fielding T, Greer AD, Latour I. An image-guided MR compatible surgical robot.  Neurosurgery 62: 286-293, 2008
  113. Sutherland GR, Tyson RL, Auer RN. Truncation of the Krebs Cycle During Hypoglycemic Coma.  Medicinal Chemistry 4:379-385, 2008.
  114. Sylaja PN, Coutts SB, Krol A, Hill MD, Demchuk AM; VISION Study Group.  When to expect negative diffusion weighted images in stroke and transcient ischemic attack.  Stroke 2008:39(6):1898-1900
  115. Sylaja PN, Coutts SB, Krol A, Hill MD, Demchuk AM for the VISION Study Group (2008). Diffusion weighted MRI negative stroke and TIA-when to expect it? Stroke; 39:1898-1900.
  116. Sylaja PN, Puetz V, Dzialowski I, Krol A, Hill MD, Demchuk AM.  Prognostic Value of CT Angiography in Patients with Suspected Vertebrobasilar Ischemia.  J Neuroimaging. 2008 Jan; 18 (1):46-49
  117. Tellez-Zenteno JF, Hunter G, Wiebe S. Injuries in people with self-reported epilepsy: a population-based study. Epilepsia 2008;49:954-961
  118. Tellez-Zenteno JF, Wiebe S. Long-term seizure and psychosocial outcomes of epilepsy surgery. Curr Treat Options Neurol. 2008;10:253-259.
  119. Tomsick T, Broderick J, Carrozella J, Khatri P, Hill MD, Palesch YY, Khoury J, for IMS II Investigators.  Revascularization results in IMS II, AJNR 2008; Mar;29(3):582-587
  120. Toth C. Epidemiology of Neurological Sports Injuries, Neurologic Clinics, February 2008, 26(1):1.31.
  121. Toth C. Neuroepidemiology of Sports Injury, Trauma and Neurology, 2nd edition, Oxford Press, London, Chapter 25, 479-524
  122. Toth C. Peripheral Nerve Injuries in Sports and Recreation, Neurologic Clinics, February 2008, 26(1): 89-113.
  123. Toth C, Au S. A prospective identification of neuropathic pain in specific peripheral neuropathy syndromes and response to pharmacological therapy. Pain 2008 Sep 15;138(3):657-66.
  124. Toth C, Lee HK, Samuels BA, Shim SY, Liu WQ, Martinez J, Xu Y, Ayala R, Wang J, Zochodne D, Tsai L and Nguyen MD. Ndel1 promotes axon regeneration via intermediate filaments, PLOS One, 2008 Apr 23;3(4):e2014.
  125. Toth C, Martinez JA, Chen YY,  Diggle J,  Fang Q,  Ramji N, Hoke A,  Zochodne DW. Local erythropoietin signalling enhances regeneration in peripheral axons, Neuroscience, 2008;154(2):767-83
  126. Toth C, Rong LL, Yang C, Martinez J, Song F, Ramji N, Brussee V, Liu W, Durand J,Nguyen MD, Schmidt AM, Zochodne DW. RAGE and experimental diabetic neuropathy. Diabetes. 2008 Apr; 57(4):1002-17.
  127. Toth C, Shim SY, Wang J, Jiang Y, Neumayer G, Liu W-Q, Martinez J, Zochodne D, Nguyen. MD. Ndel1 promotes axon regeneration via intermediate filaments. PLoS ONE 3(4):e2014,2008
  128. Viswanathan A, Patel P, Rahman R, Nandigam RN, Kinnecom C, Bracoud L, Rosand J, Chabriat H, Greenberg SM, Smith EE. Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke. 2008;39:1988-1992
  129. Wang LM, Rahn JJ, Lun X, Sun B, Kelly JP, Weiss S, Robbins SMR, Forsyth PA*, Senger DL*. Intramembrane Proteolysis of the p75 Neurotrophin Receptor (p75NTR) is required for Glioma Invasion.  PLoS Biol., 6: 2496-2511, 2008.  .
  130. Webber CW, Xu YQ, Vanneste KJ, Martinez JA, Verge VM, Zochodne DW. Guiding adult mammalian sensory axons during regeneration. Journal of Neuropathology and Experimental Neurology 67(3): 212-22, 2008
  131. Weir NU, A neurological letter from Calgary, Canada.  Practical Neurology 2008;8:128-132
  132. Weir NU.  An update on cardioembolic stroke. Postgraduate Medical Journal 2008;84:133-142
  133. Weir NU, Dennis MSA triumph of hope and expediency over experience and reason?JNNP 2008;79:852
  134. Wiebe S.  “Organization of Health Care in Different Countries: Canada”.  In:  Epilepsy.  Engel,J.,Jr.; Pedley,T.A.  Lippincott Williams & Wilkins, Philadelphia, 2008;Volume III:2859-2863.
  135. Wiebe S.  Why do some patients have seizures after brain surgery while others do not?  A comment on the evidence.  In:  Puzzling Cases of Epilepsy, Second Edition.  Schmidt D and Schacter S (eds).  Elsevier Inc Academic Press 2008:494-496.
  136. Wiebe S, Tellez-Zenteno J, Shapiro M.  An evidence based approach to the first seizure.  Epilepsia 2008;49(Suppl 1):50-57
  137. Wirrell E, Kozlik S, Tellez J, Wiebe S, Hamiwka L. Ambulatory electroencephalography (EEG) in children: diagnostic yield and tolerability. J Child Neurol. 2008;23:655-662
  138. Wu Y*, Lun XQ*, Zhou H, Sun B, Bell JC, Barrett J, McFadden G,  Biegel JA, Senger DL, Forsyth, PA.  Oncolytic efficacy of recombinant vesicular stomatitis virus (VSVΔM51) and myxoma virus in experimental models of malignant rhabdoid tumours.  Clinical Cancer Research 14:1218-27, 2008.
  139. Xu QG, Midha R, Martinez JA, Guo GF, Zochodne DW.  Facilitated sprouting in a peripheral nerve injury.  Neuroscience 152(4):877-87,2008
  140. Xue M, Fan Y, Liu s, Zygun D, Demchuk A, Yong VW.  Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral hemorrhage.” Brain 2008: Sept 4 [Epub ahead of print]
  141. Zhang Y, Metz LM, Yong VW, Bell RB, Yeung M, Patry DG, Mitchell JR. Pilot study of minocycline in relapsing-remitting multiple sclerosis. Can J Neurol Sci. 2008 May;35(2):185-191
  142. Zhu H, Hill MD.  Risk Adjustment using the Elixhauser Index by ICD-9-CM and ICD-10 for Stroke Case Fatality.  Neurology 2008; Jul 22;71(40);283-287
  143. Zochodne DW. Diabetic polyneuropathy. An update. Current Opinion in Neurology  21(5):527-33. 2008
  144. Zochodne DW, Ramji N, Toth C. Neuronal targeting in diabetes mellitus: a story of sensory neurons and motor neurons. Neuroscientist. 2008 Aug;14(4):311-8.